Zai Lab announces $250M private placement
- Zai Lab (ZLAB) entered into a securities purchase agreement to sell 11.34M ADSs in a private investment in public equity (PIPE) financing at $22.04 per ADS.
- Gross proceeds are expected to be approximately $250M, before placement agent fees and other offering expenses.
- The transaction is expected to close on or about October 27, 2026.
- Net proceeds primarily to support the continued global development of zocilurtatug pelitecan (zoci), its DLL3-targeting antibody-drug conjugate (ADC).
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.